Fleischmann R, Curtis JR, Charles-Schoeman C, Mysler E, et al. Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme. Ann Rheum Dis 2023 Jun 12:ard-2023-223916. doi: 10.1136/ard-2023-223916.
PMID: 37308218